Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2025 05:00 ET | Source: Yaqrit

Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease

Yaqrit strengthens board and senior management with seasoned industry leaders. Poised to implement late stage clinical strategy in advanced liver disease.
April 05, 2023 08:30 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders

Glen Rock, N.J., April 05, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
June 07, 2022 07:00 ET | Source: Lumiii

Lumiii Partners with University College London's EdTech Labs to Fundamentally Reshape Education Through Its Learn-to-Earn Gaming and Anime Series

TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Secret Pirates Entertainment Inc., creators of The Secret Order of Lumiiis franchise, announces Lumiii has partnered with University College London's (UCL)...
February 22, 2022 09:15 ET | Source: Qualigen Therapeutics, Inc.

Qualigen Therapeutics CEO Michael Poirier Provides Letter to Shareholders

CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...
September 03, 2019 02:00 ET | Source: Autolus Therapeutics plc

Autolus Announces Publication in Nature Medicine of Data Supporting the Development of AUTO1 for Treatment of Patients with ALL

Findings from Phase I CARPALL Trial Demonstrate that Autolus’ Novel CAR T Therapy, AUTO1, Induces Enhanced Anti-tumor Response Without Severe Cytokine Release Syndrome 86% molecular complete...
March 29, 2019 16:03 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019

LONDON, March 29, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the...
March 04, 2019 06:30 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Present New Data on AUTO1 at the American Association of Cancer Research (AACR) Annual Meeting 2019

LONDON, March 04, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
February 28, 2019 08:00 ET | Source: Xtera

Xtera and UCL demonstrate a record 74.38 Tbit/s per fiber transmission over transoceanic distances

ALLEN, Texas and LONDON, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Xtera®, a provider of innovative subsea fiber optic technology, today demonstrates the benefits of its advanced and novel approach to...